Loading clinical trials...
Loading clinical trials...
Aortic valve regurgitation (AR) is a common complication following surgery for subaortic stenosis (SAS), yet the long-term outcomes and risk factors for postoperative significant AR (SAR) remain poorl...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital
NCT07197736 · Valve Disease, Aortic, Mitral Regurgitation (MR), and more
NCT06918795 · Single-ventricle, Congenital Heart Disease
NCT07477197 · Adult Congenital Heart Disease, Pulmonary Hypertension, and more
NCT05647213 · Univentricular Heart, Congenital Heart Disease, and more
NCT07453407 · Aortic Regurgitation, Aortic Valve Insufficiency, and more
Fuwai Hospital
Beijing, Beijing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions